Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 85551-85600 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06599372
Evaluation of the Efficacy of Transcranial Magnetic Stimulation on Resistant Auditory Hallucinations in Schizophrenia
NARecruiting
30 participants
Started: Jul 11, 2022 · Completed: Nov 30, 2027
3 conditions1 sponsor1 location
NCT04965636
Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)
PHASE3Active, not recruiting
16 participants
Started: Jul 11, 2022 · Completed: Oct 9, 2025
1 condition1 sponsor14 locations
NCT05288777
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
PHASE2/PHASE3Recruiting
45 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2029
4 conditions1 sponsor1 location
NCT05329103
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
PHASE1Recruiting
65 participants
Started: Jul 11, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor7 locations
NCT05075317
Time Restricted Eating and Cardiac Rehabilitation
NARecruiting
60 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05100888
Theta-burst rTMS in Schizophrenia to Ameliorate Negative and Cognitive Symptoms
NAEnrolling by invitation
90 participants
Started: Jul 11, 2022 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT05232136
OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer
PHASE1/PHASE2Recruiting
30 participants
Started: Jul 11, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05460273
A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)
PHASE1/PHASE2Active, not recruiting
119 participants
Started: Jul 11, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors21 locations
NCT04915248
Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.
PHASE2Recruiting
28 participants
Started: Jul 11, 2022 · Completed: Jan 1, 2026
1 condition2 sponsors18 locations
NCT05142241
Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial
PHASE2Active, not recruiting
14 participants
Started: Jul 11, 2022 · Completed: Sep 29, 2026
4 conditions1 sponsor2 locations
NCT05420454
A Study for the Neoadjuvant Treatment of Breast Cancer
PHASE4Recruiting
1,576 participants
Started: Jul 10, 2022 · Completed: Dec 20, 2027
1 condition1 sponsor1 location
NCT04685577
Safety, Tolerability and Efficacy of Nefopam Cream in Burn Patients
PHASE2Recruiting
60 participants
Started: Jul 10, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05420467
A Study for the Adjuvant Treatment of Breast Cancer
PHASE4Recruiting
2,413 participants
Started: Jul 10, 2022 · Completed: Dec 20, 2027
1 condition1 sponsor1 location
NCT05461664
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA
N/ARecruiting
74 participants
Started: Jul 10, 2022 · Completed: Dec 31, 2025
3 conditions22 sponsors1 location
NCT04848636
Cardiac Tissue Sodium Assessment in CKD Patients Using Sodium MRI
N/ARecruiting
150 participants
Started: Jul 10, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05447169
Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening
N/ARecruiting
11,625 participants
Started: Jul 10, 2022 · Completed: Jul 1, 2030
1 condition9 sponsors1 location
NCT05408728
Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome
N/AEnrolling by invitation
52 participants
Started: Jul 10, 2022 · Completed: Aug 31, 2026
3 conditions1 sponsor1 location
NCT05722535
Using Shared Decision Making to Improve Family Media Use Planning
NARecruiting
300 participants
Started: Jul 10, 2022 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT07064746
Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma
N/ARecruiting
150 participants
Started: Jul 10, 2022 · Completed: Jul 10, 2027
1 condition2 sponsors1 location
NCT05214859
Enhancing Mother-Child Ties and Psychosocial Wellness Through Arts Among Children With Intellectual Disability and Their Mothers
NARecruiting
154 participants
Started: Jul 9, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05485077
A Prospective Cohort Study on Colorectal Cancer Screening in Community Population
N/ARecruiting
18,000 participants
Started: Jul 9, 2022 · Completed: Jul 9, 2028
1 condition2 sponsors1 location
NCT05464875
A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors
N/ARecruiting
74 participants
Started: Jul 9, 2022 · Completed: Dec 31, 2025
3 conditions22 sponsors1 location
NCT05433350
Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients
PHASE2/PHASE3Active, not recruiting
35 participants
Started: Jul 9, 2022 · Completed: Mar 31, 2026
3 conditions1 sponsor6 locations
NCT05614765
Evaluation of Dyslipidemia Management After Statin and Ezetimibe Complex Treatment
N/AActive, not recruiting
18,000 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05364606
Patient Specific Talus Spacer Post Approval Study
N/ARecruiting
50 participants
Started: Jul 8, 2022 · Completed: Nov 30, 2029
1 condition1 sponsor6 locations
NCT05463133
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists
PHASE1/PHASE2Recruiting
50 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2032
1 condition1 sponsor1 location
NCT04763109
Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence
NARecruiting
15 participants
Started: Jul 8, 2022 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT05725967
Endoscopic Metabolic and Bariatric Therapies
N/AEnrolling by invitation
5,000 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2026
16 conditions1 sponsor1 location
NCT05839106
Phase I/IIa Study for PM1032 in the Treatment of Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
200 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT06321640
Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.
N/ARecruiting
265 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2025
8 conditions1 sponsor1 location
NCT05262907
Ventripoint Single Ventricle Study
NARecruiting
100 participants
Started: Jul 8, 2022 · Completed: Aug 31, 2027
2 conditions1 sponsor1 location
NCT05616884
Cemented vs. Cementless Unicompartmental Knee Arthroplasty
NAEnrolling by invitation
100 participants
Started: Jul 8, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05113537
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
PHASE1/PHASE2Recruiting
30 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2027
7 conditions3 sponsors1 location
NCT05360446
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
PHASE3Active, not recruiting
610 participants
Started: Jul 8, 2022 · Completed: Oct 26, 2026
1 condition1 sponsor89 locations
NCT05469607
The ElectRx Study - A Neurotechnology Approach to the Treatment of IBD
NARecruiting
13 participants
Started: Jul 8, 2022 · Completed: Jul 31, 2028
1 condition5 sponsors1 location
NCT06946264
Characterization of Bronchodilator Response in Children With Bronchiolitis Using Phenotypic and Genotypic Features
PHASE3Recruiting
400 participants
Started: Jul 8, 2022 · Completed: Dec 31, 2030
2 conditions1 sponsor1 location
NCT05973656
Role of Acetaldehyde in the Development of Oral Cancer
NARecruiting
170 participants
Started: Jul 8, 2022 · Completed: Sep 30, 2027
3 conditions2 sponsors1 location
NCT05549921
Phase II Study of TAEST16001 in Soft Tissue Sarcoma
PHASE2Recruiting
70 participants
Started: Jul 8, 2022 · Completed: Sep 1, 2024
1 condition2 sponsors2 locations
NCT06653270
Virtual Reality Birth Simulator
NARecruiting
300 participants
Started: Jul 8, 2022 · Completed: Jul 30, 2025
4 conditions1 sponsor1 location
NCT06087679
The SongDanceT1 Study: Stress, Ongoing Self- Monitoring and Diabetes, Nerve Stimulation and Cognitive Empowerment.
NAActive, not recruiting
120 participants
Started: Jul 8, 2022 · Completed: Feb 1, 2024
2 conditions2 sponsors1 location
NCT05338970
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
PHASE3Active, not recruiting
586 participants
Started: Jul 8, 2022 · Completed: Jun 30, 2026
3 conditions2 sponsors182 locations
NCT06223932
Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients.
N/AActive, not recruiting
2,600 participants
Started: Jul 7, 2022 · Completed: Feb 29, 2024
2 conditions2 sponsors8 locations
NCT05426681
Spinal Cord Injury Neuroprotection With Glyburide
PHASE1Recruiting
12 participants
Started: Jul 7, 2022 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT05250466
A Comparative Study on the Efficacy of AI Temperature-controlled Radiofrequency Technology and Electrical Stimulation in the Treatment of Vulvar Leukoplakia
NARecruiting
120 participants
Started: Jul 7, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05464823
Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma
NAActive, not recruiting
111 participants
Started: Jul 7, 2022 · Completed: May 12, 2027
1 condition1 sponsor1 location
NCT05463536
Improvings: Implementing a Protocol to Improve Intrapartum Sonography Skills.
N/ARecruiting
20 participants
Started: Jul 7, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05116527
THC Memory & Reward Learning Pilot
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Jul 7, 2022 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT04674462
Understanding Poor Vaccine Responses to Hepatitis B Vaccination
PHASE4Recruiting
200 participants
Started: Jul 7, 2022 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT05261477
Brain Injury Education and Outpatient Navigation-1stBIEN
NARecruiting
300 participants
Started: Jul 7, 2022 · Completed: Dec 31, 2026
2 conditions2 sponsors6 locations
NCT04982796
Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder
PHASE1/PHASE2Recruiting
30 participants
Started: Jul 7, 2022 · Completed: Apr 30, 2026
1 condition2 sponsors1 location